Research
@Rowan

Technology Categories

Rowan University » Research @Rowan » Office of Research » Commercialization » Industry » Available Technologies
Advanced Search

Search Results - tae+won+kim

2 Results Sort By:
Injectable hydrogels with independent control over physical properties and bioactive peptide functionalization
Osteoporosis is the most common bone disease that causes low bone mass, bone tissue deterioration, and bone microarchitecture disruption, leading to compromised bone strength and an increased risk of fractures. More than 200 million people have osteoporosis globally, and about 30% of women and 20% of men over 50 will experience an osteoporotic fracture...
Published: 2/9/2024   |   Inventor(s): Sebastián Vega, Kirstene Gultian, Tae Won Kim
Keywords(s):  
Category(s): Engineering
Novel Biodegradable and Non-biodegradable 3D Printed Implants
TechnologyMusculoskeletal diseases are the second most common cause of disability with cost to the healthcare industry in upwards of $5 billion per year. Current implants designed to treat these diseases are plagued by various complications including infection, immune rejection, and inadequate osteointegration. New technologies are needed to overcome...
Published: 3/6/2024   |   Inventor(s): Shivakumar Ranganathan, Tae Won Kim
Keywords(s): 3D, Biodegradable, Drug Delivery, Implant, Orthopedics, Tissue Engineering
Category(s): Human Health Care > Biomaterials, Human Health Care > Medical Devices